📊 Removal Estimates

Estimates based on drug properties and standard treatment parameters.

🩸

170.6 mL/min

Highly Dialyzable

Significant removal expected. Consider post-dialysis supplementation.

Data Used:
✅ protein_binding, molar_mass, mw_factor
⚠️ Missing: vd, half_life

Free fraction: 0.79 Mw factor: 1 Vd factor: 0.8 Hl factor: 1 Half life: N/A Half life category: Unknown

🫀

5.2 mL/min

Moderate PD Clearance

Some removal possible, but likely not clinically significant.

Data Used:
✅ protein_binding, molar_mass
⚠️ Missing: half_life

Free fraction: 0.79 Half life: N/A Half life category: Unknown

🔄

Unable to Assess

Insufficient data for TPE risk assessment. Protein binding and Vd required.

Data Used:
✅ protein_binding
⚠️ Missing: vd, half_life

Half life: N/A Half life category: Unknown

🧪

Cannot Assess

Vd data required for hemoadsorption effectiveness assessment.

Data Used:

⚠️ Missing: vd, half_life

Half life: N/A Half life category: Unknown

Modality	Clearance/Value	Half-Life	Classification	Data Quality
Hemodialysis	170.6 mL/min	N/A	Highly Dialyzable	Partial Data
Peritoneal Dialysis	5.2 mL/min	N/A	Moderate PD Clearance	Partial Data
Plasmapheresis (TPE)	Unable to Assess	N/A	N/A	Partial Data
Hemoadsorption	Cannot Assess	N/A	N/A	Partial Data

Hemodialysis: Estimates based on high-flux dialyzer (urea clearance 270 mL/min), Qb 300 mL/min, 4-hour session.
Peritoneal Dialysis: Estimates based on CAPD (Continuous Ambulatory Peritoneal Dialysis).
TPE: Risk assessment based on protein binding and volume of distribution.
Hemoadsorption: Effectiveness based on volume of distribution. Most effective for drugs with Vd < 0.2 L/kg.
Data Quality: Estimates with missing data use default assumptions. Consider adding missing data for more accurate predictions.
Clinical Note: These are descriptive estimates only. Always consult clinical guidelines and monitor drug levels when available.